Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Phillip M. Schneider files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Justin Chakma - $1.48M in SPRY purchases and sales in the last 12 months
- Eric Karas - $250K in SPRY purchases and sales in the last 12 months
- Brian Dorsey - $190K in SPRY purchases and sales in the last 12 months
- Alexander A. Fitzpatrick - $34K in SPRY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Phillip M. Schneider?
Phillip M. Schneider is a corporate insider of ARS Pharmaceuticals, Inc. (SPRY). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Phillip M. Schneider last file a Form 4?
The most recent primary Form 4 on record is dated 26 June 2026, one of 3 filings going back to 2024.
